Shennon Biotechnologies

BiotechnologySeedSan Francisco, USshennonbio.com

Latest round

Seed

Last raised

Dec 2022

Total raised

$7.3M

Investors

3

About Shennon Biotechnologies

Based in California, US, and founded in 2021, Shennon Biotechnologies operates as a biotechnology research company that develops treatments for solid tumors and later autoimmune diseases. The company was founded by its CEO Li Sun. In September 2026, Shennon Biotechnologies Inc. The firm uses an ultra-high throughput single-cell platform which helps the company to profile immune cells on single cell level and pull-out targets. This platform helps the firm to create immunotherapies. The firm plans to use the September 2026 fundingt o advance its cancer treatment programs and support development of its T-cell engager platform for clinical studies.

Who invested in Shennon Biotechnologies

3 investors across 1 round

See all investors in Shennon Biotechnologies

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 21, 2022

    Amount

    $7.3M

    Investors

    Locked

Questions about Shennon Biotechnologies

Who invested in Shennon Biotechnologies?

Shennon Biotechnologies has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Shennon Biotechnologies raised?

Shennon Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Shennon Biotechnologies last raise money?

Shennon Biotechnologies's most recent round on record is a Seed, in Dec 2022.

What does Shennon Biotechnologies do?

Based in California, US, and founded in 2021, Shennon Biotechnologies operates as a biotechnology research company that develops treatments for solid tumors and later autoimmune diseases.

Where is Shennon Biotechnologies headquartered?

Shennon Biotechnologies is headquartered in San Francisco, US.

Which VCs invest in companies like Shennon Biotechnologies?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Shennon Biotechnologies's stage. Their profiles are linked below.

Raising like Shennon Biotechnologies? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.